{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:46:16Z","timestamp":1779252376235,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011488","name":"Health and Family Planning Committee of Pudong New Area","doi-asserted-by":"publisher","award":["PWZzk2017-24"],"award-info":[{"award-number":["PWZzk2017-24"]}],"id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["European J Hybrid Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p><jats:sup>68<\/jats:sup>Ga-fibroblast activation protein-specific enzyme inhibitor 04 (FAPI-04) is a radiolabelled molecular agent targeting the inhibitor of fibroblast activation protein (FAP), which is often present in tumor stroma and inflammatory tissue with prominent fibroblast proliferation. FAPI-04 is a promising PET tracer for tumor imaging as well as IgG4-related disease (IgG4-RD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case description<\/jats:title>\n                <jats:p>We herein present a case where <jats:sup>68<\/jats:sup>Ga-FAPI PET\/MR helped to diagnose IgG4-RD that involved pancreas and bile duct. A 62-year-old patient suffered from diffusive discomfort at middle upper abdomen and presented brown urine. Blood test revealed abnormal liver function and elevated IgG4 (4.830g\/L\u2191). <jats:sup>18<\/jats:sup>F-FDG PET showed enlarged uncinate process and dilated bile duct tree. Mild increase of FDG uptake in uncinate process and head of pancreas indicated possible pancreatic malignancy, but the clinical evidence was not sufficient and histology examination was negative. <jats:sup>68<\/jats:sup>Ga-FAPI PET revealed prominent increased radioactivity distribution in the entire pancreas and bile duct, suggesting IgG4-RD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>FAPI-04 is not only a good PET imaging tracer for tumors, but also for prominent fibroblast-mediated inflammation. FAPI imaging should be considered when the diagnosis using <jats:sup>18<\/jats:sup>F-FDG imaging is ambiguous. The presented case illustrates that <jats:sup>68<\/jats:sup>Ga-FAPI-04 PET is helpful in improving the differential diagnosis of pancreatitis and pancreatic cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41824-021-00106-1","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T23:06:35Z","timestamp":1623711995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["68Ga-FAPI-04 PET\/MR is helpful in differential diagnosis of pancreatitis from pancreatic malignancy compared to 18F-FDG PET\/CT: a case report"],"prefix":"10.1186","volume":"5","author":[{"given":"Yi","family":"Shou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-5512","authenticated-orcid":false,"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"issue":"9","key":"106_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, J\u00e4ger D, Mier W, Haberkorn U (2018) Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med 59(9):1415\u20131422. https:\/\/doi.org\/10.2967\/jnumed.118.210443","journal-title":"J Nucl Med"},{"key":"106_CR2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W et al (2018) A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med 59:1423\u20131429. https:\/\/doi.org\/10.2967\/jnumed.118.210435","journal-title":"J Nucl Med"},{"issue":"12","key":"106_CR3","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s00259-019-04478-2","volume":"46","author":"Y Luo","year":"2019","unstructured":"Luo Y, Pan Q, Zhang W (2019 Nov) IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET\/CT. Eur J Nucl Med Mol Imaging 46(12):2625\u20132626. https:\/\/doi.org\/10.1007\/s00259-019-04478-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"106_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2967\/jnumed.120.244723","volume":"62","author":"Y Luo","year":"2020","unstructured":"Luo Y, Pan Q, Yang H, Peng L, Zhang W, Li F (2020a) Fibroblast activation protein targeted PET\/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET\/CT. J Nucl Med 62(2):266\u2013271. https:\/\/doi.org\/10.2967\/jnumed.120.244723","journal-title":"J Nucl Med"},{"issue":"4","key":"106_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/RLU.0000000000002914","volume":"45","author":"Y Luo","year":"2020","unstructured":"Luo Y, Pan Q, Zhang W, Li F (2020b Apr) Intense FAPI uptake in inflammation may mask the tumor activity of pancreatic cancer in 68Ga-FAPI PET\/CT. Clin Nucl Med 45(4):310\u2013311. https:\/\/doi.org\/10.1097\/RLU.0000000000002914","journal-title":"Clin Nucl Med"},{"issue":"6","key":"106_CR6","first-page":"557","volume":"12","author":"VX Nguyen","year":"2011","unstructured":"Nguyen VX, Nguyen CC, Nguyen BD (2011) 18FDG PET\/CT imaging of the pancreas: spectrum of diseases. Journal of the Pancreas 12(6):557\u2013566","journal-title":"Journal of the Pancreas"},{"issue":"4","key":"106_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/RLU.0000000000002919","volume":"45","author":"Q Pan","year":"2020","unstructured":"Pan Q, Luo Y, Zhang W (2020 Apr) Recurrent immunoglobulin G4-related disease shown on 18F-FDG and 68Ga-FAPI PET\/CT. Clin Nucl Med 45(4):312\u2013313. https:\/\/doi.org\/10.1097\/RLU.0000000000002919","journal-title":"Clin Nucl Med"},{"key":"106_CR8","doi-asserted-by":"publisher","unstructured":"R\u00f6hrich M, Naumann P, Giesel FL et al (2020) Impact of 68Ga-FAPI-PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas. J Nucl Med:jnumed.120.253062. https:\/\/doi.org\/10.2967\/jnumed.120.253062","DOI":"10.2967\/jnumed.120.253062"},{"issue":"8","key":"106_CR9","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","volume":"41","author":"J Zhang","year":"2014","unstructured":"Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, Wang X, Liang Z, Zhang F, Li F, Zhang W, Zhu Z (2014) Characterizing IgG4-related disease with 18F-FDG PET\/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 41(8):1624\u20131634. https:\/\/doi.org\/10.1007\/s00259-014-2729-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"106_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/RLU.0000000000001901","volume":"43","author":"L Zheng","year":"2018","unstructured":"Zheng L, Xing H, Li F, Huo L (2018 Jan) Focal autoimmune pancreatitis mimicking pancreatic cancer on FDG PET\/CT imaging. Clin Nucl Med 43(1):57\u201359. https:\/\/doi.org\/10.1097\/RLU.0000000000001901","journal-title":"Clin Nucl Med"}],"container-title":["European Journal of Hybrid Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-021-00106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-021-00106-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-021-00106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T23:06:49Z","timestamp":1623712009000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhi.springeropen.com\/articles\/10.1186\/s41824-021-00106-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1186\/s41824-021-00106-1","relation":{},"ISSN":["2510-3636"],"issn-type":[{"value":"2510-3636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was taken from the patient for the publication of this case report and related imaging.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}